For almost 15 years, men all over the world in the world ceased to tremble and mrachnyi the word “impotence” – they know in case of any problems of an intimate nature, they come to the aid of the now legendary, the drug to return to “the weak of the stronger sex” the ability to experience the joys of love. But as discovered recently, the American researchers, the famous drug has another extremely useful property: Viagra is able to improve not only erection, but also the effectiveness of the drug with which to treat cancer. Moreover, “Viagra” besides, significantly reduces dangerous side effects of antineoplastic agents.
Antitumor antibiotic doxorubicin a long time and quite successfully used by oncologists around the world for the treatment of malignant tumors of different etiology and localization. Doxorubicin effect on cancer of the breast, bladder, thyroid cancer, acute leukemia, Hodgkin’s disease and some other oncological diseases.
However, like every other cytostatic doxorubicin has side effects: stomatitis, nausea and vomiting, hair loss. But in addition to these General enough for drugs such appointment side effects doxorubicin is cardiotoxic threat effect: in the process of its application, the patient can develop irregular heart rhythm, heart failure, lowering blood pressure.
But scientists from the American research centers Virginia Commonwealth University School of Medicine and VCU Massey Cancer Center has made a very important discovery: the use of doxorubicin in combination with sildenafilom (“Viagra”) in the treatment of prostate cancer not only significantly reduced the side effects of cytostatics, but also significantly strengthened its main effect is a destructive effect on tumor cells.
In the near future, scientists plan to move to clinical trials a new “tandem” doxorubicin + “Viagra”.
“We believe sildenafil could be an excellent candidate for inclusion in treatment regimens of cancer – he has a pronounced enhancement effect of anticancer effects and simultaneously protects the heart from the side effects of doxorubicin and directly with the treatment, and in the distant future,” reports Kukreja Rakesh (Rakesh Kukreja), who led the researchers who have made such an important discovery.